International Business Machines (IBM) picked up two separate catalysts within roughly a day this week, and only one came from a stock analyst.
JPMorgan upgraded IBM (IBM) to Overweight on Tuesday and raised its price target to $291 from $270, a call built entirely on the company’s software business, according to a Seeking Alpha report.
A day earlier, IBM picked up a different kind of momentum tied to a White House signing ceremony and a new OpenAI partnership, unrelated to quarterly earnings.
IBM has spent the last decade reshaping itself around software, hybrid cloud, and now artificial intelligence.
The stock matters to investors less as a growth story and more as a test of whether legacy tech companies can convert AI hype into recurring revenue.
Tuesday’s upgrade argues IBM is pulling that off, adding to a run of bullish calls already stacking up on the name.
More IBM:
- IBM and Google team up to launch stunning product for customers
- Wedbush resets IBM stock price target on AI momentum
- IBM CEO sends strong message on quantum computing
JPMorgan’s call is a bet on software margins, not mainframes
JPMorgan analyst Brian Essex raised IBM to Overweight from Neutral and lifted his price target to $291 from $270, according to a Seeking Alpha report. Essex argued software, not hardware, is now the primary driver of IBM’s stock, with the higher-margin business mix continuing to expand.
Software already accounts for roughly 45% of IBM’s revenue and close to two thirds of its profit, a mix Essex expects to keep tilting further.
That ratio is why a slowdown in IBM’s server business matters less than it used to, since the segment driving most of the profit is barely touched by it.
Essex flagged softness in Red Hat Enterprise Linux tied to a weaker server demand industrywide, but expects that offset by OpenShift migration, automation gains from HashiCorp, and contributions from the recently acquired Confluent data platform.
He also noted IBM is lapping a tough comparison from last year’s z17 mainframe cycle, calling that less relevant to long-term growth.
JPMorgan isn’t alone in that view:
- Citigroup rates IBM at Buy with a $375 price target, the highest among major coverage.
- Barclays initiated coverage this month at Overweight with a $350 target.
- Wedbush carries an Outperform rating and a $320 target.
- Morgan Stanley raised its target to $267 from $225 this week, though it kept a more cautious Equal Weight rating.
President Trump signed two executive orders accelerating quantum computing and post-quantum cryptography adoption.
Andrew Harnik / Getty Images
A White House signing and an OpenAI deal landed within a day of each other
A day before JPMorgan’s call, President Trump signed two executive orders accelerating quantum computing research and speeding migration to quantum-resistant cryptography.
One order targets a research-grade quantum computer by 2028, while the second pushes federal agencies toward post-quantum cryptography on an accelerated timeline.
IBM CEO Arvind Krishna attended the signing alongside Alphabet President Ruth Porat, a reminder the policy reaches beyond IBM alone.
The same Monday, IBM said it joined OpenAI’s Daybreak Cyber Partner Program, launching an application security service that uses OpenAI’s models to identify and validate software vulnerabilities inside client environments.
The service runs on IBM’s existing consulting AI platform with read-only access to client code, building on Project Lightwell, a $5 billion commitment IBM made with Red Hat earlier this year.
Neither announcement appears in JPMorgan’s note. Essex’s upgrade is a fundamentals case built on software margins and recurring revenue already showing up in IBM’s results.
The quantum order and OpenAI partnership are policy and product news with no disclosed revenue attached yet. They landed close together by scheduling, not shared evidence.
IBM’s week mirrors a bet the broader market is making
IBM Vice Chairman Gary Cohn argued this week that the stock market would be struggling in 2026 if investors stripped out gains tied to artificial intelligence and energy, according to a Seeking Alpha report.
Cohn described the two trades as increasingly intertwined, with AI infrastructure spending pushing power demand higher and energy stocks rising alongside it.
His point was about the index broadly, not IBM specifically, but it describes the same dynamic playing out in IBM’s stock this week.
A software upgrade grounded in margin math landed within a day of a policy-driven AI catalyst with no disclosed revenue behind it.
IBM shares were up 4.25% Tuesday to around $260, the clearest sign yet that Wall Street is pricing all three storylines, software margins, the quantum order, and the OpenAI partnership, into the stock at once.
JPMorgan’s case for IBM stands on its own, built on acquisitions and recurring revenue already visible in the numbers.
But the speed at which Wall Street rewarded the quantum and AI headlines is the same pattern Cohn flagged at the index level, leaving IBM’s stock exposed to a sentiment shift that has nothing to do with its software business.